Transmucosal gastric leak induced by proton pump inhibitors

Digestive Diseases and Sciences

Volumn 54, Issue 7, 2009, Pages 1408-1417

  Murray, Lisa J ^a,b   Gabello, Melissa ^a,b   Rudolph, David S ^c   Farrell, Christopher P ^c   Morgan, Melissa ^c   Martin, Aaron P ^a   Underwood, James C ^a   Valenzano, M Carmen ^a   Mullin, James M ^c  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SAINT JOSEPH S UNIVERSITY   (United States)

^c LANKENAU HOSPITAL   (United States)

Author keywords

Epithelial permeability; Gastric leak; Omeprazole; Proton pump inhibitor; Tight junction

Indexed keywords

CARBON 14; DEXTRAN; ESOMEPRAZOLE; LANSOPRAZOLE; MACROGOL; MANNITOL; OMEPRAZOLE; SUCROSE;

ACID SECRETION; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EX VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT CIRCUIT CURRENT; STOMACH FISTULA; STOMACH MUCOSA; TRANSMUCOSAL GASTRIC LEAK;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANTI-ULCER AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; GASTRIC MUCOSA; HYDROGEN-ION CONCENTRATION; MALE; OMEPRAZOLE; PERMEABILITY; PROTON PUMP INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67349171087     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0528-z     Document Type: Article

References (68)

1. MI Wilde D McTavish 1994 Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders Drugs 48 91 132 10.2165/00003495- 199448010-00008 (Pubitemid 24223942)
2. B Wallmark P Lorentzon H Larsson 1985 The mechanism of action of omeprazole-a survey of its inhibitory actions in vitro Scand J Gastroenterol Suppl 108 37 51 10.3109/00365528509095818 (Pubitemid 15064509)
3. H Larsson E Carlsson U Junggren 1983 Inhibition of gastric acid secretion by omeprazole in the dog and rat Gastroenterology 85 900 907
4. L Olbe T Lind C Cederberg 1986 Effect of omeprazole on gastric acid secretion in man Scand J Gastroenterol Suppl 118 105 107 10.3109/ 00365528609090908 (Pubitemid 16107570)
5. Mullin JM, Valenzano MC, Whitby M, et al. Esomeprazole induces upper gastrointestinal tract transmucosal permeability (R2). Aliment Pharmacol Ther. 2008 (in press).
6. AM Hopkins C McDonnell NP Breslin 2002 Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue J Pharm Pharmacol 54 341 347 10.1211/0022357021778583
7. B Hameed DM Smith JJ Verrechio 2004 Indocyanine green alters transepithelial electrical parameters of the distal colon Dig Dis Sci 49 1381 1386 10.1023/B:DDAS.0000042234.52224.a5
8. JM Mullin CW Marano KV Laughlin 1997 Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets J Cell Physiol 171 226 233 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B
9. JM Mullin JM Leatherman MC Valenzano ER Huerta J Verrechio DM Smith 2005 Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes Mol Biol Cell 16 5538 5550 10.1091/mbc.E05-04-0294
10. AG Catto-Smith JL Ripper 1995 Mucosal mast cells and developmental changes in gastric absorption Am J Physiol 268 G121 G127
11. MJ Jackson SH Norris 1985 Transport of sodium and chloride across rat gastric mucosa in vitro J Physiol 360 293 310 (Pubitemid 15133998)
12. T Andersson M Hassan-Alin G Hasselgren 2001 Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole Clin Pharmacokinet 40 523 537 10.2165/00003088-200140070-00004 (Pubitemid 32743165)
13. L Scaringi P Cornacchione E Ayroldi 2004 Omeprazole induces apoptosis in jurkat cells Int J Immunopathol Pharmacol 17 331 342 (Pubitemid 39481676)
14. Y Shiono Y Fujita S Oka 2002 ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells Anticancer Res 22 2907 2911
15. M Yeo DK Kim YB Kim 2004 Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells Clin Cancer Res 10 8687 8696 10.1158/1078-0432.CCR-04-1065
16. A De Milito E Iessi M Logozzi 2007 Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species Cancer Res 67 5408 5417 10.1158/0008-5472.CAN- 06-4095
17. W Schillinger N Teucher S Sossalla 2007 Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms Circulation 116 57 66 10.1161/CIRCULATIONAHA.106.666008
18. Y Sarioglu S Yildirim T Utkan 2000 Evidence of relaxant effect of omeprazole in rabbit corpus cavernosum in vitro Life Sci 66 1411 1421 10.1016/S0024-3205(00)00452-5
19. E Naseri A Yenişehirli 2006 Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries Eur J Pharmacol 531 226 231 10.1016/j.ejphar.2005.12.025
20. K Yildirim Y Sarioglu T Kaya 2001 Inhibitor effect of omeprazole in isolated human myometrial smooth muscle Life Sci 69 435 442 10.1016/S0024- 3205(01)01135-3
21. + ionophore Inflamm Res 56 105 111 10.1007/s00011-006-6127-6
22. C Aydin B Sarac A Koyuncu 2003 Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro J Gastroenterol 38 765 771 10.1007/s00535-003-1143-6
23. A Yenişehirli R Onur 2006 Specific H+/K+-ATPase inhibitors decreased contractile responses of isolated rat vas deferens Pharmacol Res 54 397 405 10.1016/j.phrs.2006.07.005
24. H Suzuki T Masaoka Y Minegishi 2004 Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase Wound Repair Regen 12 93 99 10.1111/j.1067-1927.2004.012116.x
25. H Clarke CW Marano A Peralta Soler 2000 Modification of tight junction function by protein kinase C isoforms Adv Drug Deliv Rev 41 283 301 10.1016/S0169-409X(00)00047-8
26. Y Chen Q Lu EE Schneeberger 2000 Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells Mol Biol Cell 11 3 849 862 (Pubitemid 30159306)
27. N Yoshida T Yoshikawa Y Tanaka 2000 A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions Aliment Pharmacol Ther 14 74 81 10.1046/j.1365-2036.2000. 014s1074.x (Pubitemid 30199109)
28. A Varro S Kenny E Hemers 2007 Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling Am J Physiol Gastrointest Liver Physiol 292 G1133 G1140 10.1152/ajpgi.00526.2006
29. S Joelson IB Joelson P Lundborg 1992 Safety experience from long-term treatment with omeprazole Digestion 51 93 101
30. M Fried H Siegrist R Frei 1994 Duodenal bacterial overgrowth during treatment in outpatients with omeprazole Gut 35 23 26 10.1136/gut.35.1.23 (Pubitemid 24059466)
31. NH Cox 1992 Acute disseminated epidermal necrosis due to omeprazole Lancet 340 857 10.1016/0140-6736(92)92739-3
32. MR Haeney 1992 Angio-edema and urticaria associated with omeprazole BMJ 305 870
33. M Lindquist IR Edwards 1992 Endocrine adverse effects of omeprazole BMJ 305 451 452
34. L Santucci F Farroni S Fiorucci 1991 Gynecomastia during omeprazole therapy N Engl J Med 324 635
35. S Bank R Greenberg 1991 Alternate day omeprazole in H2 receptor-antagonist (H2RA) resistant reflux esophagitis Gastroenterology 100 A29
36. JL Raoul JF Bretagne A Ropert 1992 Zollinger-Ellison syndrome, antisecretory treatment, and body weight Dig Dis Sci 37 1308 1309 10.1007/BF01296581
37. JP Dutertre D Soutif AP Jonville 1991 Sexual disturbances during omeprazole therapy Lancet 338 1022 10.1016/0140-6736(91)91887-Z
38. S Sellapah 1990 An unusual side effect of omeprazole: case report Br J Gen Pract 40 389
39. PB Christensen KE Albertsen P Jensen 1993 Renal failure after omeprazole Lancet 341 55 10.1016/0140-6736(93)92531-W (Pubitemid 23007633)
40. JJ Kuiper 1993 Omeprazole-induced acute interstitial nephritis Am J Med 95 248 10.1016/0002-9343(93)90273-R (Pubitemid 23242726)
41. SJ Ruffenach MS Siskind YH Lien 1992 Acute interstitial nephritis due to omeprazole Am J Med 93 472 473 10.1016/0002-9343(92)90181-A
42. ML Lee DW Piper GO Fischer 1989 Lichen spinulosus after the ingestion of omeprazole Med J Aust 150 410
43. DR Marks JV Joy NA Bonheim 1991 Hemolytic anemia associated with the use of omeprazole Am J Gastroenterol 86 217 218
44. G Brunner C Athmann JH Boldt 2001 Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases Dig Dis Sci 46 993 996 10.1023/A:1010745624971
45. V Jochem R Kirkpatrick J Greenson 1992 Fulminant hepatic failure related to omeprazole Am J Gastroenterol 87 523 525
46. R Gonthier K Bouchou C Guy P Cathebras H Rousset 1993 Severe hyponatremia induced by meprazole Presse Med 22 176
47. A Rudelli I Leduc C Traulle 1993 Thrombopenia following treatment with omeprazole Presse Med 22 966
48. FJ Garrote C Lacambra T del Ser 1992 Subacute myopathy during omeprazole therapy Lancet 340 672 10.1016/0140-6736(92)92205-T
49. N Kakei M Ichinose M Tatematsu 1995 Effects of long-term omeprazole treatment on adult rat gastric mucosa-enhancement of the epithelial cell proliferation and suppression of its differentiation Biochem Biophys Res Commun 214 861 868 10.1006/bbrc.1995.2366
50. M Jalving JJ Koornstra J Wesseling 2006 Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy Aliment Pharmacol Ther 24 1341 1348 10.1111/j.1365-2036.2006.03127.x
51. T Zhang SJD O'Keefe T Winter 1998 Effect of chronic duodenal ulceration and its treatment with lanzoprazole or sucralfate on gastroduodenal mucosal protein turnover and TGF-alpha, bFGF, and EGF receptor expression in humans Dig Dis Sci 43 2764 2770 10.1023/A:1026680017329
52. G Rindi R Fiocca A Morocutti 2005 Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa Eur J Gastroenterol Hepatol 17 559 566 10.1097/00042737-200505000-00013
53. KG Nørsett A Laegreid M Langaas 2005 Molecular characterization of rat gastric mucosal response to potent acid inhibition Physiol Genomics 22 24 32 10.1152/physiolgenomics.00245.2004
54. T Hagiwara K Mukaisho ZQ Ling 2007 Rebamipide contributes to reducing adverse effects of long-term administration of omeprazole in rats Dig Dis Sci 52 988 994 10.1007/s10620-006-9415-7
55. JH Walsh 1990 Role of gastrin as a trophic hormone Digestion 47 suppl 1 11 16 discussion 49-52
56. F Hollande A Choquet EM Blanc 2001 Involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinases in glycine-extended gastrin-induced dissociation and migration of gastric epithelial cells J Biol Chem 276 40402 40410 10.1074/jbc.M105090200
57. S Weber JE Zuckerman DG Bostwick KG Bensch BI Sikic TA Raffin 1985 Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro J Clin Invest 75 306 309 10.1172/JCI111690 (Pubitemid 15163999)
58. S Dagogo-Jack S Atkinson P Kendall-Taylor 1985 Homologous radioimmunoassay for epidermal growth factor in human saliva J Immunoassay 6 125 136 10.1080/01971528508063025 (Pubitemid 15074209)
59. PE Jørgensen TN Rasmussen P Skov Olsen 1990 Renal uptake and excretion of epidermal growth factor from plasma in the rat Regul Pept 28 273 281 10.1016/0167-0115(90)90025-R
60. JM Mullin 2004 Epithelial barriers, compartmentation, and cancer Sci STKE 2004 216 pe2 10.1126/stke.2162004pe2
61. A Viste K ∅vrebø H Maartmann-Moe H Waldum 2004 Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux Gastric Cancer 7 31 35 10.1007/s10120-003-0264-1
62. GJ Wetscher RA Hinder T Smyrk 1999 Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux Dig Dis Sci 44 1132 1135 10.1023/A:1026615905170
63. JR Graham 1992 Gastric polyposis: onset during long-term therapy with omeprazole Med J Aust 157 287 288
64. GD Bell KU Powell 1993 Eradication of Helicobacter pylori and its effect in peptic ulcer disease Scand J Gastroenterol Suppl 196 7 11 10.3109/00365529309098334 (Pubitemid 23175426)
65. J Labenz E Gyenes GH Rühl 1993 Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori Am J Gastroenterol 88 491 495 (Pubitemid 23106579)
66. P Unge A Gad H Gnarpe 1989 Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study Scand J Gastroenterol Suppl 167 49 54 10.3109/00365528909091311 (Pubitemid 19265491)
67. CA Kiley DJ Cragin BJ Roth 2007 Omeprazole-associated digoxin toxicity South Med J 100 400 402 (Pubitemid 46559170)
68. M Homma F Itagaki K Yuzawa 2002 Effects of lansoprazole and rabeprazole on tacrolimus blood concentration: case of a renal transplant recipient with CYP2C19 gene mutation Transplantation 73 303 304 10.1097/00007890-200201270- 00028 (Pubitemid 34112860)